Literature DB >> 23969955

Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation.

Yonka Christova1, Colin Adrain, Paul Bambrough, Ashraf Ibrahim, Matthew Freeman.   

Abstract

Loss of iRhom2, a catalytically inactive rhomboid-like protein, blocks maturation of TACE/ADAM17 in macrophages, resulting in defective shedding of the cytokine tumor necrosis factor. Apart from the resulting inflammatory defects, iRhom2-null mice appear normal: they do not show the several defects seen in TACE knockouts, suggesting that TACE maturation is independent of iRhom2 in cells other than macrophages. Here we show that the physiological role of iRhoms is much broader. iRhom1 knockout mice die within 6 weeks of birth. They show a severe phenotype, with defects in several tissues including highly penetrant brain haemorrhages. The non-overlapping phenotypes imply that iRhom 1 and 2 have distinct physiological roles, although at a cellular level both promote the maturation of TACE (but not other ADAM proteases). Both iRhoms are co-expressed in many contexts where TACE acts. We conclude that all TACE activity, constitutive and regulated, requires iRhom function. iRhoms are therefore essential and specific regulators of TACE activity, but our evidence also implies that they must have additional physiologically important clients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23969955      PMCID: PMC3807218          DOI: 10.1038/embor.2013.128

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  26 in total

1.  Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE.

Authors:  Colin Adrain; Markus Zettl; Yonka Christova; Neil Taylor; Matthew Freeman
Journal:  Science       Date:  2012-01-13       Impact factor: 47.728

2.  Multiple Loci modulate opioid therapy response for cancer pain.

Authors:  Antonella Galvan; Frank Skorpen; Pål Klepstad; Anne Kari Knudsen; Torill Fladvad; Felicia S Falvella; Alessandra Pigni; Cinzia Brunelli; Augusto Caraceni; Stein Kaasa; Tommaso A Dragani
Journal:  Clin Cancer Res       Date:  2011-05-27       Impact factor: 12.531

3.  Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE).

Authors:  J Schlöndorff; J D Becherer; C P Blobel
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

4.  The lack of ADAM17 activity during embryonic development causes hemorrhage and impairs vessel formation.

Authors:  Matthias Canault; Kaan Certel; Daphne Schatzberg; Denisa D Wagner; Richard O Hynes
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

5.  Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.

Authors:  Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

6.  iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.

Authors:  Priya Darshinee A Issuree; Thorsten Maretzky; David R McIlwain; Sébastien Monette; Xiaoping Qing; Philipp A Lang; Steven L Swendeman; Kyung-Hyun Park-Min; Nikolaus Binder; George D Kalliolias; Anna Yarilina; Keisuke Horiuchi; Lionel B Ivashkiv; Tak W Mak; Jane E Salmon; Carl P Blobel
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

7.  Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice.

Authors:  Richard W Gelling; Wenbo Yan; Salwa Al-Noori; Aaron Pardini; Gregory J Morton; Kayoko Ogimoto; Michael W Schwartz; Peter J Dempsey
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

8.  Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells.

Authors:  Huafei Zou; Sufi M Thomas; Zhen-Wen Yan; Jennifer R Grandis; Andreas Vogt; Lu-Yuan Li
Journal:  FASEB J       Date:  2008-10-02       Impact factor: 5.191

9.  RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.

Authors:  Diana C Blaydon; Sarah L Etheridge; Janet M Risk; Hans-Christian Hennies; Laura J Gay; Rebecca Carroll; Vincent Plagnol; Fiona E McRonald; Howard P Stevens; Nigel K Spurr; D Timothy Bishop; Anthony Ellis; Janusz Jankowski; John K Field; Irene M Leigh; Andrew P South; David P Kelsell
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

10.  Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling.

Authors:  Markus Zettl; Colin Adrain; Kvido Strisovsky; Viorica Lastun; Matthew Freeman
Journal:  Cell       Date:  2011-04-01       Impact factor: 41.582

View more
  60 in total

Review 1.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

2.  L-selectin shedding affects bacterial clearance in the lung: a new regulatory pathway for integrin outside-in signaling.

Authors:  Anika Cappenberg; Andreas Margraf; Katharina Thomas; Bernadette Bardel; Dylan A McCreedy; Veerle Van Marck; Alexander Mellmann; Clifford A Lowell; Alexander Zarbock
Journal:  Blood       Date:  2019-10-24       Impact factor: 22.113

3.  Loss of RHBDF2 results in an early-onset spontaneous murine colitis.

Authors:  Ramasatyaveni Geesala; Willow Schanz; Mikayla Biggs; Garima Dixit; Joseph Skurski; Prajwal Gurung; David K Meyerholz; David Elliott; Priya D Issuree; Thorsten Maretzky
Journal:  J Leukoc Biol       Date:  2019-01-29       Impact factor: 4.962

Review 4.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

5.  iRhom2 regulates CSF1R cell surface expression and non-steady state myelopoiesis in mice.

Authors:  Lindsay Rogers; Arthur Mortha; Carl P Blobel; Jane E Salmon; Xiaoping Qing; Yonit Lavin; Patricia Redecha; Priya D Issuree; Thorsten Maretzky; Miriam Merad; David McIlwain; Tak W Mak; Christopher M Overall
Journal:  Eur J Immunol       Date:  2016-09-28       Impact factor: 5.532

6.  Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis.

Authors:  Xue Li; Thorsten Maretzky; Jose Manuel Perez-Aguilar; Sébastien Monette; Gisela Weskamp; Sylvain Le Gall; Bruce Beutler; Harel Weinstein; Carl P Blobel
Journal:  J Cell Sci       Date:  2017-01-19       Impact factor: 5.285

7.  iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.

Authors:  Xue Li; Thorsten Maretzky; Gisela Weskamp; Sébastien Monette; Xiaoping Qing; Priya Darshinee A Issuree; Howard C Crawford; David R McIlwain; Tak W Mak; Jane E Salmon; Carl P Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

8.  Alternative Processing of the Amyloid Precursor Protein Family by Rhomboid Protease RHBDL4.

Authors:  Sandra Paschkowsky; Mehdi Hamzé; Felix Oestereich; Lisa Marie Munter
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

9.  Rhbdf2 mutations increase its protein stability and drive EGFR hyperactivation through enhanced secretion of amphiregulin.

Authors:  Vishnu Hosur; Kenneth R Johnson; Lisa M Burzenski; Timothy M Stearns; Richard S Maser; Leonard D Shultz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-13       Impact factor: 11.205

10.  Neutrophil and Macrophage Cell Surface Colony-Stimulating Factor 1 Shed by ADAM17 Drives Mouse Macrophage Proliferation in Acute and Chronic Inflammation.

Authors:  Jingjing Tang; Jeremy M Frey; Carole L Wilson; Angela Moncada-Pazos; Clémence Levet; Matthew Freeman; Michael E Rosenfeld; E Richard Stanley; Elaine W Raines; Karin E Bornfeldt
Journal:  Mol Cell Biol       Date:  2018-08-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.